The estimated Net Worth of Rhonda J. Robb is at least $5.38 Million dollars as of 7 February 2022. Ms. Robb owns over 1,567 units of Cardiovascular Systems stock worth over $3,282,080 and over the last 7 years she sold CSII stock worth over $152,244. In addition, she makes $1,944,050 as Chief Operating Officer at Cardiovascular Systems.
Rhonda has made over 4 trades of the Cardiovascular Systems stock since 2020, according to the Form 4 filled with the SEC. Most recently she bought 1,567 units of CSII stock worth $29,334 on 7 February 2022.
The largest trade she's ever made was selling 3,600 units of Cardiovascular Systems stock on 12 February 2020 worth over $152,244. On average, Rhonda trades about 448 units every 45 days since 2018. As of 7 February 2022 she still owns at least 164,104 units of Cardiovascular Systems stock.
You can see the complete history of Ms. Robb stock trades at the bottom of the page.
Rhonda J. Robb serves as Chief Operating Officer of the Company. Ms. Robb held several positions at Medtronic, most recently as Vice President and General Manager of the Heart Valve Therapies Business from 2014 to 2018. From 2009 to 2014, Ms. Robb was Vice President and General Manager for Medtronic’s Catheter Based Therapies business. Ms. Robb was employed by Medtronic since 1990 and has served in several other leadership roles, including Vice President of Global Marketing, Coronary and Peripheral; Director Global Marketing, Heart Failure/High Power Therapies; and Director US Marketing, Cardiac Rhythm & Disease Management.
As the Chief Operating Officer of Cardiovascular Systems, the total compensation of Rhonda Robb at Cardiovascular Systems is $1,944,050. There are 1 executives at Cardiovascular Systems getting paid more, with Scott Ward having the highest compensation of $4,718,960.
Rhonda Robb is 52, she's been the Chief Operating Officer of Cardiovascular Systems since 2018. There are 15 older and 10 younger executives at Cardiovascular Systems. The oldest executive at Cardiovascular Systems Inc. is Augustine Lawlor, 64, who is the Independent Director.
Rhonda's mailing address filed with the SEC is 1225 OLD HIGHWAY 8 NW, , ST. PAUL, MN, 55112.
Over the last 16 years, insiders at Cardiovascular Systems have traded over $72,999,461 worth of Cardiovascular Systems stock and bought 949,532 units worth $8,687,068 . The most active insiders traders include Capital Management Lp Camber, Augustine Lawlor, and Capital Ltdmaverick Capital.... On average, Cardiovascular Systems executives and independent directors trade stock every 14 days with the average trade being worth of $338,920. The most recent stock trade was executed by Martha Goldberg Aronson on 15 August 2022, trading 2,411 units of CSII stock currently worth $48,220.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company's orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.
Cardiovascular Systems executives and other stock owners filed with the SEC include: